Liveyon Stem Cell Pure Product, Liveyon Stem Cells for Regenerative Medicine

Liveyon PURE® Debuts Clinical Trial Grade Stem Cell Concentrate Derived from Umbilical Cord Blood

Liveyon Labs Sets New Industry Standard for Characterization and Consistency in Live Total Nucleated Cell Counts, Viability, Purity and Safety   YORBA LINDA, Calif. – February 28, 2019 – Liveyon, the global leader in regenerative medicine, today announced the availability of Liveyon PURE®, a clinical trial grade stem cell concentrate derived from umbilical cord blood. […]
Liveyon Blog, Latest updates on Liveyon Stem Cells for Regenerative Medicine

Liveyon Pure® Products (White Paper)

This report reviews the qualities and characteristics of the Liveyon PURE® products (PURE® and PURE PRO®). The data shows the viability of the cells before and after freezing, characterizes cell surface markers and growth factor expression, and the mixture of cells that make up the product’s composition. Key terms: Regenerative medicine, umbilical cord blood, cell […]
Hair and Skin Treatments, Liveyon Pure Cast Podcast

Liveyon Pure Cast – The Liveyon FDA Product Recall. (E05) Part 2 of 2

For more Liveyon Pure Cast Podcast videos subscribe to our YouTube channel at: Episode 5 – Liveyon Pure Cast – The Liveyon FDA Product Recall Part 2 of 2 Dr. Alan Gaveck: Welcome back everybody. Dr. Alan Gaveck medical … Director of Medical education for Liveyon along with John Kosolcharoen, CEO and Founder of Liveyon. We’re […]
Hair and Skin Treatments, Liveyon Pure Cast Podcast

Liveyon Pure Cast – The Making and Launch of Liveyon Pure® (E03)

For more Liveyon Pure Cast Podcast videos subscribe to our YouTube channel at: Episode 3 – Liveyon Pure Cast – The Making and Launch of Liveyon Pure® Dr. Alan Gaveck: Welcome back everybody, Dr. Alan Gaveck here with Liveyon and the Liveyon Pure Cast. I’m here with our CEO and founder today, John Kosolcharoen. I want […]
Hair and Skin Treatments, Liveyon Pure Cast Podcast

Liveyon Pure Cast – The Stem Cell Market Bubble. (E02)

For more Liveyon Pure Cast Podcast videos subscribe to our YouTube channel at: Episode 2 – Liveyon Pure Cast – The Stem Cell Market Bubble Dr. Alan Gaveck: Hey welcome back to the Liveyon Pure cast, I guess that’s the Pure Podcast. John Kosolcharoen: The Pure podcast on YouTube. Dr. Alan Gaveck: Right on. Today I’m with […]
Ep 1 Liveyon Pure Cast - Who is Liveyon? The Origin Story, Liveyon Stem Cells

Liveyon Pure Cast – Who is Liveyon? The Origin Story (E01)

 For more Liveyon Pure Cast Podcast videos subscribe to our YouTube channel at: Episode 1 – Liveyon Pure Cast – Who is Liveyon? The Origin Story Dr. Alan Gaveck: All right. You want to do this thing? John Kosolcharoen: We’re going to do it. Dr. Alan Gaveck: All right, let’s go. John Kosolcharoen: All right. Dr. […]
Hair and Skin Treatments, Liveyon Pure Cast Podcast

Liveyon Pure Cast – The Controversial 361 Designation Explained. (E06)

For more Liveyon Pure Cast Podcast videos subscribe to our YouTube channel at: Episode 6 – Liveyon Pure Cast – The Controversial 361 Designation Explained Dr. Alan Gaveck:  Welcome back to the Liveyon Pure Cast. I’m here with John Kosolcharoen CEO and founder of Liveyon, and Liveyon Labs. John, a few podcasts back, we talked […]
Liveyon FDA Recall, Liveyon Pure Cast Podcast, Stem Cells for Regenerative Medicine

From Recall to Rebirth: Liveyon Ready to Reinvent Regenerative Medicine

 For more Liveyon Pure Cast Podcast videos subscribe to our YouTube channel at: Behind-the-Scenes Look at Events Surrounding FDA Recall of Genetech Products and Plans for Liveyon to Produce its Own Stem Cell Concentrate Derived from Umbilical Cord Blood. YORBA LINDA, Calif. – February 26th, 2019 – For many companies in the fledgling stem […]
Translate »
 

 

Medical Professional Viewing Only (Disclaimer)


This site was intended for education purposes only and strictly for use by medical professionals. The FDA recently re-confirmed, there is only one registered stem cell product, and while there is enormous promise in stem cell therapies, and thousands of ongoing experimental applications trying to establish efficacy, these are not at the point where they would meet the scientific standard.
The FDA has stated:
Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.
http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194655.htm
This site is not intended for consumers.
If you are considering stem cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the stem cells are your own. Even if the cells are yours, there are safety risks, including risks introduced when the cells are manipulated after removal.
“There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body.” Cells in a different environment may multiply, form tumors, or may leave the site you put them in and migrate somewhere else.
If you are considering having stem cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a stem cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate stem cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their stem cell products.
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm286155.htm
Stem cell therapies have enormous promise, but the science in each use is still in the developmental stage. Professional judgment and expertise is needed in using stem cells for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies to consult the national health data bases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.